| Literature DB >> 30976459 |
M J E Urlings1, B Duyx1, G M H Swaen1, L M Bouter2,3, M P Zeegers1,4.
Abstract
INTRODUCTION: Bisphenol A is highly debated and studied in relation to a variety of health outcomes. This large variation in the literature makes BPA a topic that is prone to selective use of literature, in order to underpin one's own findings and opinion. Over time, selective use of literature, by means of citations, can lead to a skewed knowledge development and a biased scientific consensus. In this study, we assess which factors drive citation and whether this results in the overrepresentation of harmful health effects of BPA.Entities:
Keywords: Bisphenol A; Citation analysis; Methodology; Questionable research practice; Selective citation
Year: 2019 PMID: 30976459 PMCID: PMC6440006 DOI: 10.1186/s41073-019-0065-7
Source DB: PubMed Journal: Res Integr Peer Rev ISSN: 2058-8615
Fig. 1Flow diagram of the network selection process
Characteristics of the bisphenol A network of 169 publications, 12,432 potential citation pathways and 808 realized citations
| Variable | Categories | Number of publications | Number of potential citation pathways (% citations realized) |
|---|---|---|---|
| Study outcome | |||
| Statistical significance | Yes | 40 | 2800 (8%) |
| No | 36 | 2813 (5%) | |
| Mixed | 47 | 3819 (9%) | |
| Not reported | 46 | 2800 (8%) | |
| Authors’ conclusion | In line with hypothesis | 92 | 6826 (7%) |
| Not in line with hypothesis | 28 | 2114 (4%) | |
| Mixed | 32 | 2658 (5%) | |
| Unclear | 17 | 834 (9%) | |
| Content-related determinants | |||
| Health outcome | Reproductive outcomes | 49 | 3853 (7%) |
| Metabolic diseases | 45 | 3218 (8%) | |
| Intermediate health factors | 24 | 1594 (2%) | |
| Hormone production | 18 | 1300 (8%) | |
| Birth outcomes | 11 | 971 (6%) | |
| Behavioral outcomes | 7 | 557 (3%) | |
| Cancer | 4 | 286 (2%) | |
| Other | 11 | 653 (6%) | |
| Study design | Cohort study | 34 | 2471 (7%) |
| Cross-sectional study | 63 | 5013 (9%) | |
| Case-control study | 29 | 2019 (4%) | |
| Narrative review | 35 | 2374 (4%) | |
| Systematic review | 8 | 555 (5%) | |
| Sample size* | < 168 | 42 | 3259 (6%) |
| 168–430 | 42 | 3154 (6%) | |
| > 430 | 43 | 3212 (10%) | |
| Title of publication | Suggestive of conclusion | 33 | 2327 (5%) |
| Not suggestive of conclusion | 136 | 10,105 (7%) | |
| Not content-related determinants | |||
| Number of affilations* | < 3 | 51 | 4241 (5%) |
| 3–5 | 59 | 3445 (7%) | |
| > 5 | 59 | 4746 (7%) | |
| Journal impact factor* | < 2.85 | 60 | 4188 (5%) |
| 2.85–4.6 | 53 | 4210 (7%) | |
| > 4.6 | 56 | 4034 (8%) | |
| Funding source | Not for profit | 135 | 10,548 (7%) |
| For profit | 0 | 0 (0%) | |
| Both | 4 | 369 (7%) | |
| Funding not reported | 20 | 968 (3%) | |
| No funding applicable | 10 | 547 (3%) | |
| Number of references* | < 46 | 65 | 4152 (7%) |
| 46–58 | 47 | 4200 (8%) | |
| > 58 | 57 | 4080 (5%) | |
| Corresponding author-related determinants | |||
| Gender | Male | 86 | 7359 (7%) |
| Female | 74 | 4472 (6%) | |
| Unknown | 9 | 601 (3%) | |
| Affiliation | University | 136 | 10,403 (8%) |
| Government | 14 | 925 (6%) | |
| Industry | 1 | 132 (1%) | |
| Other | 18 | 1152 (7%) | |
| Continent | America | 73 | 6022 (8%) |
| Asia | 47 | 3612 (5%) | |
| Europe | 42 | 2425 (4%) | |
| Australia | 1 | 35 (3%) | |
| Africa | 2 | 181 (2%) | |
| Middle East | 4 | 157 (0%) | |
*For descriptive purposes, continuous variables have been transformed to categories based on tertiles
Fig. 2Visualization of the citation network, depicting the 100 most cited studies in the network. The y-axis depicts the timeline of publications, and the x-axis is solely for visualization purposes. Each circle and square is one publication, indicated by the name of the first author. The squares are the four most cited publications in the network. Each line indicates a performed citation from one publication to another
Sensitivity analysis: crude and adjusted odds ratios for the chance of being cited, excluding two highly cited publications (> 50 citations)
| Variable | Categories | Crude OR | Adjusted OR* |
|---|---|---|---|
| Significance | Yes vs no | 1.57 (1.28–1.92) | 1.48 (1.21–1.80) |
| Authors’ conclusion | In line vs not in line with hypothesis | 1.45 (1.18–1.77) | 1.53 (1.25–1.87) |
| Study design | Narrative review | 1.00 (ref) | |
| Cross-sectional study | 4.44 (3.26–6.04) | ||
| Case-control study | 2.61 (1.88–3.62) | ||
| Cohort study | 3.93 (2.82–5.46) | ||
| Systematic review | 3.28 (2.22–4.85) | ||
| Sample size** | < 168 | 1.00 (ref) | 1.00 (ref) |
| 168–430 | 1.03 (0.87–1.21) | 0.98 (0.84–1.16) | |
| > 430 | 1.40 (1.09–1.79) | 1.22 (0.97–1.54) | |
| Title of publication | Conclusive title vs non-conclusive title | 1.07 (0.91–1.25) | 0.96 (0.82–1.12) |
| Number of afilliations** | < 3 | 1.00 (ref) | 1.00 (ref) |
| 3–5 | 1.46 (1.21–1.77) | 1.06 (0.86–1.30) | |
| > 5 | 1.09 (0.86–1.38) | 0.70 (0.55–0.90) | |
| Journal impact factor** | < 2.8 | 1.00 (ref) | 1.00 (ref) |
| 2.8–4.6 | 1.62 (1.41–1.87) | 1.38 (1.19–1.60) | |
| > 4.6 | 1.59 (1.33–1.89) | 1.43 (1.20–1.70) | |
| Funding source | Not reported vs reported | 0.46 (0.34–0.63) | 0.83 (0.62–1.13) |
| Number of references** | < 46 | 1.00 (ref) | 1.00 (ref) |
| 46–58 | 1.07 (0.92–1.24) | 0.96 (0.82–1.12) | |
| > 58 | 0.51 (0.42–0.61) | 0.56 (0.46–0.69) | |
| Gender of corresponding author | Male vs female | 1.14 (1.01–1.28) | 1.20 (1.05–1.37) |
| Affiliation of corresponding author | Private vs public sector | 1.07 (0.86–1.35) | 1.08 (0.85–1.38) |
| Authority of the authors** | < 3 | 1.00 (ref) | 1.00 (ref) |
| 3–26 | 2.26 (1.85–2.76) | 2.09 (1.68–2.60) | |
| > 26 | 2.75 (2.18–3.47) | 2.69 (2.08–3.48) | |
| Self-citation | Yes vs no | 5.46 (4.09–7.28) | 5.05 (3.75–6.81) |
*Adjusted model is adjusted for study design
**Continuous variables were categorized based on tertiles
Univariate and multivariate analyses on potential determinants of the likelihood of being cited
| Variable | Categories | Crude OR | Adjusted OR* |
|---|---|---|---|
| Study outcome | |||
| Significance | Yes vs no | 1.57 (1.28–1.92) | 1.48 (1.21–1.80) |
| Authors’ conclusion | In line vs not in line with hypothesis | 1.57 (1.29–1.92) | 1.65 (1.34–2.03) |
| Content-related determinants | |||
| Study design | Narrative review | 1.00 (ref) | |
| Cohort study | 1.61 (1.26–2.07) | ||
| Cross-sectional study | 2.00 (1.64–2.44) | ||
| Case-control study | 1.08 (0.84–1.38) | ||
| Systematic review | 1.36 (0.99–1.87) | ||
| Sample size ** | < 168 | 1 (ref) | 1.00 (ref) |
| 168–430 | 1.04 (0.88–1.22) | 1.00 (0.85–1.17) | |
| > 430 | 1.62 (1.27–2.05) | 1.39 (1.12–1.74) | |
| Title of publication | Suggestive title vs not suggestive title | 1.25 (1.07–1.45) | 1.16 (1.00–1.35) |
| Not content-related determinants | |||
| Number of affiliations** | < 3 | 1.00 (ref) | 1.00 (ref) |
| 3–5 | 1.46 (1.22–1.75) | 1.27 (1.04–1.56) | |
| > 5 | 1.50 (1.24–1.82) | 1.32 (1.06–1.65) | |
| Journal Impact Factor** | < 2.8 | 1.00 (ref) | 1.00 (Ref) |
| 2.8–4.6 | 1.21 (1.07–1.36) | 1.08 (0.96–1.22) | |
| > 4.6 | 1.41 (1.22–1.63) | 1.22 (1.06–1.41) | |
| Funding source | For-profit vs not-for-profit *** | NA | NA |
| Not reported vs reported | 0.41 (0.31–0.55) | 0.74 (0.43–1.28) | |
| Number of references** | < 46 | 1.00(ref) | 1.00 (ref) |
| 46–58 | 1.24 (1.08–1.42) | 1.10 (0.95–1.26) | |
| > 58 | 0.75 (0.63–0.89) | 0.78 (0.65–0.92) | |
| Author-related determinants | |||
| Gender of corresponding author | Male vs Female | 1.00 (0.89–1.11) | 0.97 (0.86–1.09) |
| Affiliation of corresponding author | Private vs public sector | 0.94 (0.75–1.17) | 1.31 (0.57–3.01) |
| Authority of the authors** | < 3 | 1.00 (ref) | 1.00 (ref) |
| 3–26 | 2.21 (1.84–2.66) | 2.16 (1.78–2.63) | |
| > 26 | 3.20 (2.59–3.96) | 3.32 (2.64–4.18) | |
| Self-citation | Yes vs no | 5.14 (3.88–6.81) | 5.16 (3.81–6.99) |
*Adjusted model is adjusted for study design
**Continuous variables were categorized based on tertiles
***None of the publications was funded solely by for-profit organizations, therefore this analysis was not possible